Clinical Trials

Melanoma

At Lehigh Valley Health Network, we are committed to providing our patients and community with the best possible care and treatments. Our research scientists are integrated with our clinical departments for a comprehensive, collaborative approach to research. Have a question about clinical trials? Contact the Network Office of Research and Innovation at 610-402-9543.

Showing 4 of 4 Clinical Trials Related to Melanoma

Clinical Research Trial

Amgen 757 Lung Cancer

A Phase 3, Randomized, Double-blind, Placebo-controlled, Multicenter Study of Tarlatamab Therapy in Subjects With Limited-Stage Small-Cell Lung Cancer (LS-SCLC) who Have not Progressed Following Concurrent Chemoradiation Therapy (DeLLphi-306)

Doctor(s) Running This Study
Suresh G. Nair, MD
Nicholas E. Lamparella, DO
M. Bijoy Thomas, MD
Jeffrey T. Brodsky, MD
Brian J. Patson, MD
Maged F. Khalil, MD
Bradley W. Lash, MD
Jeanette M. Blauth, MD
Lori A. Alfonse, DO
Simi Masand Rai, MD
Don J. Park, MD, PHD
Muhammad A. Rizvi, MD
Hasan H. Danish, MD
Heiwon Chung Whang, MD
Eliot L. Friedman, MD
Tara Morrison, MD
Paul Palyca, MD
Alyson F. McIntosh, MD, MPHIL
Aaron U. Blackham, MD
Clinical Research Trial

MSK 23-098

MSK 23-098 A Phase II study of IO102/IO103 and nivolumab-relatlimab fixed dose combination in untreated, unresectable Stage III/IV melanoma

Doctor(s) Running This Study
Suresh G. Nair, MD
Clinical Research Trial

BMS CA224-098 Melanoma study

CA224-098: A Phase 3, Randomized, Double-blind Study of Adjuvant Immunotherapy With Relatlimab and Nivolumab Fixed-dose Combination Versus Nivolumab Monotherapy After Complete Resection of Stage III-IV Melanoma

Doctor(s) Running This Study
Suresh G. Nair, MD
Clinical Research Trial

SWOG S1801 Melanoma

A Phase II Randomized Study of Adjuvant Versus Neoadjuvant MK-3475 (Pembrolizumab) for Clinically Detectable Stage III-IV High Risk Melanoma

Doctor(s) Running This Study
Maged F. Khalil, MD